Century Therapeutics (IPSC) Revenue & Revenue Breakdown
Century Therapeutics Revenue Highlights
Latest Revenue (Y)
$6.59M
Century Therapeutics Revenue by Period
Century Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $6.59M | 194.81% |
| 2023-12-31 | $2.23M | -57.01% |
| 2022-12-31 | $5.20M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Century Therapeutics generated $6.59M in revenue during NA 2024, up 194.81% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Century Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $109.16M | 2515.96% |
| 2024-12-31 | $4.17M | 427.56% |
| 2024-09-30 | $791.00K | 2.59% |
| 2024-06-30 | $771.00K | -9.82% |
| 2024-03-31 | $855.00K | 219.03% |
| 2023-12-31 | $268.00K | 81.08% |
| 2023-09-30 | $148.00K | 49.49% |
| 2023-06-30 | $99.00K | -94.24% |
| 2023-03-31 | $1.72M | 230.13% |
| 2022-12-31 | $521.00K | -76.57% |
| 2022-09-30 | $2.22M | 59.31% |
| 2022-06-30 | $1.40M | 31.95% |
| 2022-03-31 | $1.06M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Century Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Century Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | $145.24M | $44.04M |
| EQ | Equillium | $41.09M | - |
| IPSC | Century Therapeutics | $6.59M | - |
| CUE | Cue Biopharma | $5.49M | $2.95M |
| COEP | Coeptis Therapeutics | - | $62.87K |
| OSTX | OS Therapies | - | - |
| OTLK | Outlook Therapeutics | - | - |
| MDCX | Medicus Pharma | - | - |
| GNTA | Genenta Science S.p.A. | - | - |
| TELO | Telomir Pharmaceuticals | - | - |
| SNTI | Senti Biosciences | - | - |